Zaharko D S, Bolten B J, Kobayashi T, Blasberg R G, Lee S S, Giovanella B C, Stehlin J S
Cancer Treat Rep. 1979 Jun;63(6):945-9.
Measurements were made to determine if millimolar thymidine (TdR) concentrations, shown to have antitumor activity in vitro, could be attained in vivo. An adaptation of an ion-exclusion liquid chromatography method was used to quantitate TdR and thymine in various biologic fluids. Millimolar concentrations of TdR were attained in plasma of mice, monkeys, and man by constant infusions of large quantities of TdR (approximately 80 g/m2/day). Cerebrospinal fluid concentrations of TdR at equilibrium were one tenth of the plasma concentration in the monkey. The primary route of removal of TdR at these high plasma concentrations is kidney clearance of intact TdR. Metabolism, which plays a major role in the clearance of TdR at micromolar concentrations in plasma, appears to be saturated at millimolar concentrations of TdR.
进行了相关测量,以确定在体外显示具有抗肿瘤活性的毫摩尔浓度胸苷(TdR)在体内是否能够达到。采用一种离子排斥液相色谱法的改良方法来定量各种生物体液中的TdR和胸腺嘧啶。通过持续输注大量TdR(约80μg/m²/天),在小鼠、猴子和人的血浆中达到了毫摩尔浓度的TdR。在猴子中,平衡时脑脊液中TdR的浓度是血浆浓度的十分之一。在这些高血浆浓度下,TdR清除的主要途径是肾脏对完整TdR的清除。代谢在血浆中微摩尔浓度的TdR清除中起主要作用,但在毫摩尔浓度的TdR时似乎已饱和。